Knight Therapeutics Announces Closing of Previously Announced Acquisition of Grupo Biotoscana

Author's Avatar
Nov 29, 2019
Article's Main Image

Transformational acquisition establishes Knight as a premiere pan-American (ex-US) specialty pharma company